Patents by Inventor Mary Lui

Mary Lui has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mammalian proteins that bind to FKBP12 in a rapamycin-dependent fashion
    Patent number: 6492106
    Abstract: A protein complex containing 245 kDa and 35 kDa components, designated RAFT1 and RAFT2 (for Rapamycin And FKBP12 Target) interacts with FKBP12 in a rapamycin-dependent manner. This interaction has the pharmacological characteristics expected from the observed in vivo effects of rapamycin: it occurs at low nanomolar concentrations of rapamycin and is competed by excess FK506. Sequences (330 amino acids total) of tryptic peptides derived from the affinity purified 245 kDa RAFT1 reveals striking homologies to the predicted products of the yeast TOR genes, which were originally identified by mutations that confer rapamycin resistance in yeast. A RAFT1 cDNA was obtained and found to encode a 289 kDa protein (2550 amino acids) that is 43% and 39% identical to TOR2 and TOR1, respectively.
    Type: Grant
    Filed: September 14, 1994
    Date of Patent: December 10, 2002
    Assignee: The Johns Hopkins University
    Inventors: David M. Sabatini, Hediye Erdjument-Bromage, Mary Lui, Paul Tempst, Solomon H. Snyder
  • Mammalian proteins that bind to FKBP12 in a rapamycin-dependent fashion
    Patent number: 6476200
    Abstract: A protein complex containing 245 kDa and 35 kDa components, designated RAFT1 and RAFT2 (for Rapamycin And FKBP12 Target) interacts with FKBP12 in a rapamycin-dependent manner. This interaction has the pharmacological characteristics expected from the observed in vivo effects of rapamycin: it occurs at low nanomolar concentrations of rapamycin and is competed by excess FK506. Sequences (330 amino acids total) of tryptic peptides derived from the affinity purified 245 kDa RAFT1 reveals striking homologies to the predicted products of the yeast TOR genes, which were originally identified by mutations that confer rapamycin resistance in yeast. A RAFT1 cDNA was obtained and found to encode a 289 kDa protein (2550 amino acids) that is 43% and 39% identical to TOR2 and TOR1, respectively.
    Type: Grant
    Filed: June 27, 1994
    Date of Patent: November 5, 2002
    Assignee: The Johns Hopkins University
    Inventors: David M. Sabatini, Hediye Erdjument-Bromage, Mary Lui, Paul Tempst, Solomon H. Snyder